Crewe Advisors’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $134K | Hold |
11,543
| – | – | 0.02% | 193 |
|
|
2025
Q1 | $85.8K | Hold |
11,543
| – | – | 0.01% | 215 |
|
|
2024
Q4 | $69.2K | Hold |
11,543
| – | – | 0.01% | 250 |
|
|
2024
Q3 | $59.1K | Sell |
11,543
-47,595
| -80% | -$244K | 0.01% | 281 |
|
|
2024
Q2 | $214K | Hold |
59,138
| – | – | 0.02% | 173 |
|
|
2024
Q1 | $190K | Sell |
59,138
-600
| -1% | -$1.93K | 0.02% | 174 |
|
|
2023
Q4 | $293K | Hold |
59,738
| – | – | 0.05% | 60 |
|
|
2023
Q3 | $326K | Hold |
59,738
| – | – | 0.06% | 59 |
|
|
2023
Q2 | $401K | Hold |
59,738
| – | – | 0.06% | 89 |
|
|
2023
Q1 | $527K | Hold |
59,738
| – | – | 0.08% | 81 |
|
|
2022
Q4 | $456K | Sell |
59,738
-113
| -0.2% | -$863 | 0.07% | 83 |
|
|
2022
Q3 | $426K | Hold |
59,851
| – | – | 0.08% | 82 |
|
|
2022
Q2 | $484K | Buy |
59,851
+613
| +1% | +$4.96K | 0.11% | 60 |
|
|
2022
Q1 | $822K | Buy |
59,238
+100
| +0.2% | +$1.39K | 0.16% | 34 |
|
|
2021
Q4 | $1.66M | Hold |
59,138
| – | – | 0.34% | 24 |
|
|
2021
Q3 | $2.01M | Hold |
59,138
| – | – | 0.48% | 18 |
|
|
2021
Q2 | $2.42M | Hold |
59,138
| – | – | 0.6% | 17 |
|
|
2021
Q1 | $2.38M | Hold |
59,138
| – | – | 0.59% | 18 |
|
|
2020
Q4 | $3.5M | Sell |
59,138
-16,870
| -22% | -$998K | 1.4% | 17 |
|
|
2020
Q3 | $3.7M | Sell |
76,008
-5,410
| -7% | -$263K | 1.73% | 13 |
|
|
2020
Q2 | $3.94M | Sell |
81,418
-11,582
| -12% | -$560K | 1.92% | 11 |
|
|
2020
Q1 | $2.58M | Buy |
+93,000
| New | +$2.58M | 1.54% | 13 |
|